{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:37:04Z","timestamp":1793083024814,"version":"4.5.0"},"reference-count":36,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"crossref","award":["ANR-17-RHUS-0003"],"award-info":[{"award-number":["ANR-17-RHUS-0003"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["H2020-847939-IP-cure-B"],"award-info":[{"award-number":["H2020-847939-IP-cure-B"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2023,9,26]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>A convenient, reproducible biomarker of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) transcriptional activity is lacking. We measured circulating HBV RNA (cirB-RNA) in untreated and nucleos(t)ide analogues (NUC) treated chronic hepatitis B (CHB) patients to define its correlation with intrahepatic viral markers and HBV core-related antigen (HBcrAg).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Paired liver biopsy and serum samples were collected from 122 untreated and 30 NUC-treated CHB patients. We measured cirB-RNA, HBV DNA, hepatitis B surface antigen (HBsAg), HBcrAg and alanine aminotransferase levels. cirB-RNA was quantified using an investigational HBV RNA assay for use on the cobas 6800 system. The test detects a region spanning the HBV canonical polyadenylation site. cccDNA and 3.5 kb RNA in liver tissue were assessed by quantitative PCR and droplet digital PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>cirB-RNA was detectable in 100% of HBeAg(+) chronic hepatitis (CH), 57% and 14% of HBeAg(\u2212) CH and chronic infection untreated patients and 47% of NUC-treated patients. cirB-RNA undetectability was associated with lower intrahepatic cccDNA transcriptional activity, as well as serum HBcrAg, but no significant differences in HBsAg, in both untreated and treated patients. In untreated HBeAg(\u2212) patients, cirB-RNA correlated with intrahepatic 3.5 kb RNA and cccDNA transcriptional activity, serum HBV DNA and HBcrAg, but not with HBsAg or total cccDNA levels. Combined undetectability of both cirB-RNA and HBcrAg detection in untreated HBeAg(\u2212) patients identified a subgroup with the lowest levels of intrahepatic transcriptionally active cccDNA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results support the usefulness of quantification of circulating HBV RNA expressed from cccDNA as an indicator of intrahepatic active viral reservoir in both untreated and NUC-treated CHB patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02602847\">NCT02602847<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2023-330644","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T13:21:06Z","timestamp":1698240066000},"page":"659-667","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":70,"title":["Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B"],"prefix":"10.1136","volume":"73","clinical-trial-number":[{"clinical-trial-number":"nct02602847","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-5465","authenticated-orcid":false,"given":"Barbara","family":"Testoni","sequence":"first","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon, Lyon, France"},{"name":"University of Lyon, UMR_S1052, CRCL, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Scholt\u00e8s","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon, Lyon, France"},{"name":"University of Lyon, UMR_S1052, CRCL, Lyon, France"},{"name":"Department of Virology, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Plissonnier","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Paturel","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon, Lyon, France"},{"name":"University of Lyon, UMR_S1052, CRCL, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Berby","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Facchetti","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Foundation IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9327-4590","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Villeret","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon, Lyon, France"},{"name":"University of Lyon, UMR_S1052, CRCL, Lyon, France"},{"name":"Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Degasperi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Foundation IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Scott","sequence":"additional","affiliation":[{"name":"Roche Molecular Diagnostics, Pleasanton, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Roche Molecular Diagnostics, Pleasanton, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marintha","family":"Heil","sequence":"additional","affiliation":[{"name":"Roche Molecular Diagnostics, Pleasanton, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1026-7476","authenticated-orcid":false,"given":"Pietro","family":"Lampertico","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Foundation IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"},{"name":"CRC \u201cA. M. and A. Migliavacca\u201d Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Levrero","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon, Lyon, France"},{"name":"University of Lyon, UMR_S1052, CRCL, Lyon, France"},{"name":"Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France"},{"name":"Department of Internal Medicine-DMISM and the IIT Center for Life Nanoscience (CLNS), Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-0083","authenticated-orcid":false,"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[{"name":"INSERM U1052, Cancer Research Center of Lyon, Lyon, France"},{"name":"University of Lyon, UMR_S1052, CRCL, Lyon, France"},{"name":"Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"key":"2025090712384050000_73.4.659.1","unstructured":"World Health Organization . Fact sheets, hepatitis B. n.d. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"key":"2025090712384050000_73.4.659.2","doi-asserted-by":"crossref","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antiviral Res"},{"key":"2025090712384050000_73.4.659.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"2025090712384050000_73.4.659.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"2025090712384050000_73.4.659.5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2025090712384050000_73.4.659.6","doi-asserted-by":"crossref","first-page":"104553","DOI":"10.1016\/j.antiviral.2019.104553","article-title":"Non-invasive biomarkers for chronic hepatitis B virus infection management","volume":"169","author":"Charre","year":"2019","journal-title":"Antiviral Res"},{"key":"2025090712384050000_73.4.659.7","doi-asserted-by":"crossref","DOI":"10.3390\/v13060951","article-title":"Novel biomarkers of hepatitis B virus and their use in chronic hepatitis B patient management","volume":"13","author":"Vachon","year":"2021","journal-title":"Viruses"},{"key":"2025090712384050000_73.4.659.8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0241","article-title":"Rnai-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025090712384050000_73.4.659.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.051"},{"key":"2025090712384050000_73.4.659.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.028"},{"key":"2025090712384050000_73.4.659.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-020-01471-2","article-title":"Serum HBV RNA correlated with Intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment","volume":"18","author":"Wang","year":"2021","journal-title":"Virol J"},{"key":"2025090712384050000_73.4.659.12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2017.08.021","article-title":"Relationship between serum HBV-RNA levels and Intrahepatic viral as well as histologic activity markers in Entecavir-treated patients","volume":"68","author":"Wang","year":"2017","journal-title":"J Hepatol"},{"key":"2025090712384050000_73.4.659.13","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00760-17"},{"key":"2025090712384050000_73.4.659.14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/infdis\/jiaa136","article-title":"Combining hepatitis B virus RNA and hepatitis B core-related antigen: guidance for safely stopping Nucleos(T)Ide analogues in hepatitis B E antigen-positive patients with chronic hepatitis B","volume":"222","author":"Fan","year":"2020","journal-title":"J Infect Dis"},{"key":"2025090712384050000_73.4.659.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.046"},{"key":"2025090712384050000_73.4.659.16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cid\/ciaa013","article-title":"Hepatitis B virus RNA as early predictor for response to pegylated interferon alpha in HBeAg-negative chronic hepatitis B","volume":"72","author":"Farag","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025090712384050000_73.4.659.17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2147\/IDR.S252994","article-title":"Serum hepatitis B virus RNA levels predict HBeAg seroconversion and virological response in chronic hepatitis B patients with high viral load treated with Nucleos(T)Ide analog","volume":"13","author":"Ji","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2025090712384050000_73.4.659.18","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.cgh.2022.06.019","article-title":"Hepatitis B RNA and core-related antigen provide value beyond DNA in evaluating E but not surface antigen clearance","volume":"21","author":"King","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090712384050000_73.4.659.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100728","article-title":"Early Intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis","volume":"5","author":"Villeret","year":"2023","journal-title":"JHEP Rep"},{"key":"2025090712384050000_73.4.659.20","doi-asserted-by":"crossref","first-page":"105150","DOI":"10.1016\/j.jcv.2022.105150","article-title":"Performance of the Cobas\u00ae HBV RNA automated investigational assay for the detection and Quantification of circulating HBV RNA in chronic HBV patients","volume":"150\u2013151","author":"Scholt\u00e8s","year":"2022","journal-title":"J Clin Virol"},{"key":"2025090712384050000_73.4.659.21","doi-asserted-by":"publisher","DOI":"10.1159\/000024982"},{"key":"2025090712384050000_73.4.659.22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27381"},{"key":"2025090712384050000_73.4.659.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.02.017"},{"key":"2025090712384050000_73.4.659.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78001-1","article-title":"Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients","volume":"10","author":"Leboss\u00e9","year":"2020","journal-title":"Sci Rep"},{"key":"2025090712384050000_73.4.659.25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328380"},{"key":"2025090712384050000_73.4.659.26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240201"},{"key":"2025090712384050000_73.4.659.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.029"},{"key":"2025090712384050000_73.4.659.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2017.12.016"},{"key":"2025090712384050000_73.4.659.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.013"},{"key":"2025090712384050000_73.4.659.30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140584","article-title":"Single hepatocytes show persistence and transcriptional inactivity of hepatitis B","volume":"5","author":"Balagopal","year":"2020","journal-title":"JCI Insight"},{"key":"2025090712384050000_73.4.659.31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100664","article-title":"Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells","volume":"5","author":"Aggarwal","year":"2023","journal-title":"JHEP Rep"},{"key":"2025090712384050000_73.4.659.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008945","article-title":"Biogenesis and molecular characteristics of serum hepatitis B virus RNA","volume":"16","author":"Shen","year":"2020","journal-title":"PLoS Pathog"},{"key":"2025090712384050000_73.4.659.33","doi-asserted-by":"crossref","first-page":"105037","DOI":"10.1016\/j.antiviral.2021.105037","article-title":"Methodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patients","volume":"189","author":"Liu","year":"2021","journal-title":"Antiviral Res"},{"key":"2025090712384050000_73.4.659.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.11.030"},{"key":"2025090712384050000_73.4.659.35","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv572"},{"key":"2025090712384050000_73.4.659.36","doi-asserted-by":"crossref","first-page":"100841","DOI":"10.1016\/j.jhepr.2023.100841","article-title":"Evaluation of the HBV liver reservoir with fine needle Aspirates","volume":"5","author":"Testoni","year":"2023","journal-title":"JHEP Reports"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-330644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:38:50Z","timestamp":1757273930000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-330644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,3,7]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/gutjnl-2023-330644"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-330644","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]}}}